Join this community!
› Share page: Email Digg del.icio.us Reddit icon StumbleUpon Technorati
Go
Search posts:

Ulysee W.'s Twitter Updates

CDC Chief Thomas Frieden thinks #H1N1 Vaccine shortage is easing? I guess he hasn't left the bubble lately. http://cli.gs/Er7PYB about 6 hours ago
FDA gives expanded indications for pediatric and adolescent treatment of schizophrenia to Eli Lilly's Zyprexa. http://cli.gs/ZVGeRt 5 days ago
RT @MaverickNY: USPSTF committee 'didn't mean' to tell women under 50 shouldn't have mammograms! http://bit.ly/5gXiDz Sounds like BS to me 8 days ago
ACS Stands Firm on Great American Smokeout; where's the CDC? Up in smoke. #smokeout #CDC #americancancersociety http://cli.gs/Phh941 22 days ago
HHS' Sebelius issues non-statement on #breastcancer recos http://bit.ly/2XKSdO She ignores that USPSTF is gov funded; policies often enactd. 23 days ago
 

Dendreon Shows Positive Results in Breast Cancer

Posted Oct 28 2008 9:56pm

Dendreon has reported positive results in the Journal of Clinical Oncology for its breast cancer vaccine Neuvenge. The vaccine showed signs of shrinking tumor size in women with her2/neu-positive breast cancer tumors. The results are very preliminary, but support moving the product from Phase I into Phase II.

Neuvenge is based on the same immune-mediated response technology as the company’s other vaccine, Provenge. Provenge was recently recommended for approval by an FDA advisory committee, although was only issued an approvable letter. The reasons for this action are cloaked in secrecy and under very suspicious circumstances (see Behind the Scenes of the Provenge ).
Post a comment
Write a comment: